Template:Atrial fibrillation: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 77: Line 77:
!
!
Special Groups
Special Groups
: [[Postoperative atrial fibrillation|Post-operative AF]]
: [[Postoperative atrial fibrillation|Postoperative AF]]
: [[Atrial fibrillation acute myocardial infarction|Acute Myocardial Infarction]]
: [[Atrial fibrillation acute myocardial infarction|Acute Myocardial Infarction]]
: [[Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes|Wolff-Parkinson-White Pre-excitation Syndrome]]
: [[Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes|Wolff-Parkinson-White Preexcitation Syndrome]]
: [[Atrial fibrillation hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
: [[Atrial fibrillation hyperthyroidism|Hyperthyroidism]]
: [[Atrial fibrillation hyperthyroidism|Hyperthyroidism]]
: [[Atrial fibrillation pregnancy|Pregnancy]]
: [[Atrial fibrillation hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
: [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]]
: [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]]
|-  
: [[Atrial fibrillation pregnancy|Pregnancy]]|-  
!
!


Line 125: Line 124:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Atrial fibrillation echocardiography or ultrasound|Echocardiography or Ultrasound]]
[[Atrial fibrillation echocardiography or ultrasound|Echocardiography]]
|-  
|-  
!
!
Line 131: Line 130:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Atrial fibrillation other imaging findings|Other Imaging Findings]]
[[Atrial fibrillation other imaging findings|Holter Monitoring]]
|-  
|-  
!
!
Line 137: Line 136:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Atrial fibrillation other diagnostic studies|Other Diagnostic Studies]]
[[Atrial fibrillation cardiac MRI|Cardiac MRI]]
|-  
|-  
!
!


|- bgcolor="CadetBlue"
|- bgcolor="LightSkyBlue"
!
!
Treatment
[[Atrial fibrillation other image findings|Exercise Stress Testing]]
|-  
|-  
!
!


|- bgcolor="PaleTurquoise"
|- bgcolor="CadetBlue"
!
!
[[Atrial fibrillation urgent treatment|Urgent Treatment]]
Treatment
|-  
|-  
!
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurguoise"
!
!
[[Atrial fibrillation overview of treatment|General Treatment Strategies]]
Cardioversion
:[[Atrial fibrillation cardioversion|Cardioversion Overview]]
:[[Atrial fibrillation electrical cardioversion|Electrical Cardioversion]]
:[[Atrial fibrillation pharmacological cardioversion|Pharmacological Cardioversion]]
|-  
|-  
!
!
Line 161: Line 163:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation anticoagulation|Anticoagulation]]
[[Atrial fibrillation anticoagulation|Anticoagulation Overview]]
: [[Warfarin]]
: [[Warfarin]]
: [[Dabigatran|Converting from or to Warfarin]]
: [[Dabigatran|Converting from or to Parenteral Anticoagulants]]
: [[Dabigatran]]
: [[Dabigatran]]
|-  
|-  
Line 169: Line 173:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Rate Control
[[Atrial fibrillation rate control|Rate Control]]
: [[Atrial fibrillation maintenance of sinus rhythm|Maintenance of Rate Control and Sinus Rhythm]]
: [[Atrial fibrillation cardioversion|Cardioversion]]
: [[Atrial fibrillation invasive treatment|Invasive Treatment]]
: [[Atrial fibrillation surgical treatment|Surgery]]
|-  
|-  
!
!
Line 179: Line 179:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation follow-up and secondary prevention|Secondary Prevention]]
[[Atrial fibrillation maintenance of sinus rhythm|Maintenance of Sinus Rhythm]]
|-  
|-  
!
!
Line 185: Line 185:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation clinical trial data|Landmark Trials]]
Surgical Options
: [[Atrial fibrillation invasive treatment|Radiofrequency ablation]]
: [[Atrial fibrillation surgical treatment|Maze Open Heart Surgery]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Atrial fibrillation secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation future or investigational therapies|Future or Investigational Therapies]]
[[Atrial fibrillation clinical trial data|Supportive Trial Data]]
|-  
|-  
!  
!  
Line 281: Line 283:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]</small>
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]</small>|-  
|-  
!  
!  



Revision as of 18:27, 12 October 2012